Cancer immunology

OJ Finn - New England Journal of Medicine, 2008 - Mass Medical Soc
Cancer Immunology | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Molecular pathways linking inflammation and cancer

A Mantovani - Current molecular medicine, 2010 - ingentaconnect.com
Inflammatory conditions in selected organs increase the risk of cancer. An inflammatory
component is present also in the microenvironment of tumours that are not epidemiologically …

Review of factors related to the thyroid cancer epidemic

Y Liu, L Su, H Xiao - International journal of endocrinology, 2017 - Wiley Online Library
Thyroid cancer is the most common endocrine cancer, of which the incidence has
dramatically increased worldwide in the past few decades. The reasons for the observed …

Molecular pathways in cancer-related inflammation

A Dep Prete, P Allavena, G Santoro, R Fumarulo… - Biochemia …, 2011 - hrcak.srce.hr
Sažetak Accumulating evidence shows that chronic inflammation is associated to increased
risk of cancer. An inflammatory component is present also in the microenvironment of …

Thyroid cancer and inflammation

V Guarino, MD Castellone, E Avilla… - Molecular and cellular …, 2010 - Elsevier
Some cancer types are strongly associated with chronic inflammatory or infectious diseases
whereas others are not, but an inflammatory component is present in most human neoplastic …

Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors

G Gasparre, AM Porcelli, E Bonora… - Proceedings of the …, 2007 - National Acad Sciences
Oncocytic tumors are a distinctive class of proliferative lesions composed of cells with a
striking degree of mitochondrial hyperplasia that are particularly frequent in the thyroid …

Androgen receptor antagonists for prostate cancer therapy

C Helsen, T Van den Broeck, A Voet… - Endocrine-related …, 2014 - erc.bioscientifica.com
Medullary thyroid carcinomas (MTC) arise from thyroid parafollicular, calcitonin-producing C-
cells and can occur either as sporadic or as hereditary diseases in the context of familial …

RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture

M Santoro, RM Melillo, A Fusco - European Journal of …, 2006 - academic.oup.com
Papillary thyroid carcinoma (PTC) is frequently associated with RET gene rearrangements
that generate the so-called RET/PTC oncogenes. In this review, we examine the data about …

Molecular pathways and targets in cancer-related inflammation

A Mantovani, C Garlanda, P Allavena - Annals of medicine, 2010 - Taylor & Francis
Selected inflammatory conditions increase the risk of cancer. An inflammatory component is
present also in the micro-environment of tumours epidemiologically unrelated to …

RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of …

KJ Rhoden, K Unger, G Salvatore… - The Journal of …, 2006 - academic.oup.com
Context: RET/papillary thyroid cancer (PTC) is a marker for papillary thyroid carcinoma, but
its specificity has been questioned because of the disputed identification of RET/PTC in …